Paclitaxel-Albumin Spirig HC 5 mg/ml, Pulver zur Herstellung einer Infusionsdispersion

7680691530012 CH-69153 Pulver
Paclitaxel-Albumin Spirig HC 5 mg/ml, Pulver zur Herstellung einer Infusionsdispersion
Paclitaxel-Albumin Spirig HC 5 mg/ml, Pulver zur Herstellung einer Infusionsdispersion
Paclitaxel-Albumin Spirig HC 5 mg/ml, Pulver zur Herstellung einer Infusionsdispersion
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Pulver
Galenic group
Lösbar zur Einnahme

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
14/05/2025
Summary of Product Characteristics
Français
14/05/2025
Summary of Product Characteristics
Italien
14/05/2025

Detailed composition

Substance Quantity Type Category
(N/A)
100.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HBESI

Reimbursement information

Public price
CHF 210.20
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/10/2024

Authorization holder

Spirig HealthCare AG

4622 Egerkingen

Authorization information

Swissmedic authorization number
69153
Drug name
Paclitaxel-Albumin Spirig HC, Pulver zur Herstellung einer Infusionsdispersion
Galenic form
PULVID
ATC Code
L01CD01
Authorization status
Z
Dispensing category
A
First authorization
27/08/2024
Authorization expiration date
26/08/2029
IT Number
07.16.1.
Domain
Human medicine
Field of application
Zytostatikum

Package details

Description (FR)
PACLITAXEL-ALBUMINE Spirig HC subst sèche 100 mg
Description (DE)
PACLITAXEL-ALBUMIN Spirig HC Trockensub 100 mg
Market launch
27/08/2024
Narcotic (BTM)
No

Original drug

Abraxane, Pulver zur Herstellung einer Infusionsdispersion
GTIN: 7680631820012
CHF 332.10
View original